Skip to main content
Toggle navigation
Languages
简体中文
English
Essential Medicines and Health Products: Prequalification of medicines
Languages
简体中文
English
Toggle Search
search
Secondary Menu
Information for
Manufacturers
Regulatory agencies
Quality control laboratories
Procurement agencies
Glossary
Contact us
Website feedback
Main menu
Home
About Us
Overview – History & Mission
What We Do
Benefits of WHO Prequalification
Success Stories
Funding
Key Contacts
Key Resources
Menu Column 1
Documents A-Z
Prequalified Lists
Medicines/finished pharmaceutical products
Active pharmaceutical ingredients
Medicines quality control laboratories
Prequalification Pipeline
Summary: FPPs & APIs invited/prequalified/under assessment
FPPs under assessment
FPPs and APIs Eligible for Prequalification ("EOIs")
Key Performance Indicators
Menu Column 2
Procedures & Fees for WHO Prequalification
Pre-submission meetings
Medicines / FPPs
Active pharmaceutical ingredients
Medicines quality control laboratories
Post-Prequalification Procedures
Amendments to APIMFs
Variations to FPPs
Requalification of FPPs
Quality monitoring
Notices of concern/suspension
Monitoring QCL performance
Prequalification Reports
WHO Public Assessment Reports
WHO Public Inspection Reports
Menu Column 3
Guidance Documents
WHO Technical Report Series
WHO medicines prequalification guidance
International Pharmacopoeia
Collaborative Procedures for Accelerated Registration
Accelerated registration of prequalified FPPs
Accelerated registration of FPPs approved by SRAs
Support to Manufacturers, CROs and QCLs
Technical advice
Pre-submission meetings
Technical assistance
Market Information
Events
News
FAQ
search
News
New WHO Public Inspection Reports (WHOPIRs) published
05 July 2018
